Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Neuroprotective effects of inter-alpha inhibitor proteins after hypoxic-ischemic brain injury in neonatal rats.

Chen X, Nakada S, Donahue JE, Chen RH, Tucker R, Qiu J, Lim YP, Stopa EG, Stonestreet BS.

Exp Neurol. 2019 Jul;317:244-259. doi: 10.1016/j.expneurol.2019.03.013. Epub 2019 Mar 23.

PMID:
30914159
2.

Choroid plexus genes for CSF production and brain homeostasis are altered in Alzheimer's disease.

Kant S, Stopa EG, Johanson CE, Baird A, Silverberg GD.

Fluids Barriers CNS. 2018 Dec 12;15(1):34. doi: 10.1186/s12987-018-0120-7.

3.

Gastrointestinal iron excretion and reversal of iron excess in a mouse model of inherited iron excess.

Mercadante CJ, Prajapati M, Parmar JH, Conboy HL, Dash ME, Pettiglio MA, Herrera C, Bu JT, Stopa EG, Mendes P, Bartnikas TB.

Haematologica. 2019 Apr;104(4):678-689. doi: 10.3324/haematol.2018.198382. Epub 2018 Nov 8.

4.

High-mobility group box-1 translocation and release after hypoxic ischemic brain injury in neonatal rats.

Chen X, Zhang J, Kim B, Jaitpal S, Meng SS, Adjepong K, Imamura S, Wake H, Nishibori M, Stopa EG, Stonestreet BS.

Exp Neurol. 2019 Jan;311:1-14. doi: 10.1016/j.expneurol.2018.09.007. Epub 2018 Sep 12.

PMID:
30217406
5.

Blood-Cerebrospinal Fluid Barrier Gradients in Mild Cognitive Impairment and Alzheimer's Disease: Relationship to Inflammatory Cytokines and Chemokines.

Ott BR, Jones RN, Daiello LA, de la Monte SM, Stopa EG, Johanson CE, Denby C, Grammas P.

Front Aging Neurosci. 2018 Aug 21;10:245. doi: 10.3389/fnagi.2018.00245. eCollection 2018.

6.

Comparative transcriptomics of choroid plexus in Alzheimer's disease, frontotemporal dementia and Huntington's disease: implications for CSF homeostasis.

Stopa EG, Tanis KQ, Miller MC, Nikonova EV, Podtelezhnikov AA, Finney EM, Stone DJ, Camargo LM, Parker L, Verma A, Baird A, Donahue JE, Torabi T, Eliceiri BP, Silverberg GD, Johanson CE.

Fluids Barriers CNS. 2018 May 31;15(1):18. doi: 10.1186/s12987-018-0102-9.

7.

Oxytocin- and arginine vasopressin-containing fibers in the cortex of humans, chimpanzees, and rhesus macaques.

Rogers CN, Ross AP, Sahu SP, Siegel ER, Dooyema JM, Cree MA, Stopa EG, Young LJ, Rilling JK, Albers HE, Preuss TM.

Am J Primatol. 2018 Oct;80(10):e22875. doi: 10.1002/ajp.22875. Epub 2018 May 24.

PMID:
29797339
8.

Memory deficiency, cerebral amyloid angiopathy, and amyloid-β plaques in APP+PS1 double transgenic rat model of Alzheimer's disease.

Klakotskaia D, Agca C, Richardson RA, Stopa EG, Schachtman TR, Agca Y.

PLoS One. 2018 Apr 11;13(4):e0195469. doi: 10.1371/journal.pone.0195469. eCollection 2018.

9.

Enteric Pathologic Manifestations of Alpha-Synucleinopathies.

Punsoni M, Friedman JH, Resnick M, Donahue JE, Yang DF, Stopa EG.

Appl Immunohistochem Mol Morphol. 2017 Nov 20. doi: 10.1097/PAI.0000000000000613. [Epub ahead of print]

PMID:
29189256
10.

Systemic infusions of anti-interleukin-1β neutralizing antibodies reduce short-term brain injury after cerebral ischemia in the ovine fetus.

Chen X, Hovanesian V, Naqvi S, Lim YP, Tucker R, Donahue JE, Stopa EG, Stonestreet BS.

Brain Behav Immun. 2018 Jan;67:24-35. doi: 10.1016/j.bbi.2017.08.002. Epub 2017 Aug 2.

11.

The Orphan C2orf40 Gene is a Neuroimmune Factor in Alzheimer's Disease.

Podvin S, Miller MC, Rossi R, Chukwueke J, Donahue JE, Johanson CE, Baird A, Stopa EG.

JSM Alzheimers Dis Relat Dement. 2016;3(1). pii: 1020. Epub 2016 Apr 1.

12.

Succinate Dehydrogenase B (SDHB) Immunohistochemistry for the Evaluation of Muscle Biopsies.

Punsoni M, Mangray S, Lombardo KA, Heath N, Stopa EG, Yakirevich E.

Appl Immunohistochem Mol Morphol. 2017 Oct;25(9):645-650. doi: 10.1097/PAI.0000000000000432.

13.

Atrophy of the tongue following complete versus partial hypoglossal nerve transection in a canine model.

Chambers KJ, Anthony DC, Randolph GW, Hartnick CJ, Stopa EG, Song PC.

Laryngoscope. 2016 Dec;126(12):2689-2693. doi: 10.1002/lary.26065. Epub 2016 Jun 8.

PMID:
27271961
14.

HMGB1 Translocation After Ischemia in the Ovine Fetal Brain.

Zhang J, Klufas D, Manalo K, Adjepong K, Davidson JO, Wassink G, Bennet L, Gunn AJ, Stopa EG, Liu K, Nishibori M, Stonestreet BS.

J Neuropathol Exp Neurol. 2016 Jun;75(6):527-38. doi: 10.1093/jnen/nlw030. Epub 2016 May 5.

15.

Expression and localization of Inter-alpha Inhibitors in rodent brain.

Chen X, Rivard L, Naqvi S, Nakada S, Padbury JF, Sanchez-Esteban J, Stopa EG, Lim YP, Stonestreet BS.

Neuroscience. 2016 Jun 2;324:69-81. doi: 10.1016/j.neuroscience.2016.03.009. Epub 2016 Mar 8.

16.

P-glycoprotein expression and amyloid accumulation in human aging and Alzheimer's disease: preliminary observations.

Chiu C, Miller MC, Monahan R, Osgood DP, Stopa EG, Silverberg GD.

Neurobiol Aging. 2015 Sep;36(9):2475-82. doi: 10.1016/j.neurobiolaging.2015.05.020. Epub 2015 Jun 6.

PMID:
26159621
17.

Human polyomavirus receptor distribution in brain parenchyma contrasts with receptor distribution in kidney and choroid plexus.

Haley SA, O'Hara BA, Nelson CD, Brittingham FL, Henriksen KJ, Stopa EG, Atwood WJ.

Am J Pathol. 2015 Aug;185(8):2246-58. doi: 10.1016/j.ajpath.2015.04.003. Epub 2015 Jun 6.

18.

Kaolin-induced chronic hydrocephalus accelerates amyloid deposition and vascular disease in transgenic rats expressing high levels of human APP.

Silverberg GD, Miller MC, Pascale CL, Caralopoulos IN, Agca Y, Agca C, Stopa EG.

Fluids Barriers CNS. 2015 Jan 24;12(1):2. doi: 10.1186/2045-8118-12-2. eCollection 2015.

19.

Ischemia/Reperfusion-induced neovascularization in the cerebral cortex of the ovine fetus.

Virgintino D, Girolamo F, Rizzi M, Ahmedli N, Sadowska GB, Stopa EG, Zhang J, Stonestreet BS.

J Neuropathol Exp Neurol. 2014 Jun;73(6):495-506. doi: 10.1097/NEN.0000000000000071.

20.

Noninvasive fractal biomarker of clock neurotransmitter disturbance in humans with dementia.

Hu K, Harper DG, Shea SA, Stopa EG, Scheer FA.

Sci Rep. 2013;3:2229. doi: 10.1038/srep02229.

21.

Severe impairment of circadian rhythm in Alzheimer's disease.

Volicer L, Harper DG, Stopa EG.

J Nutr Health Aging. 2012 Oct;16(10):888-90. doi: 10.1007/s12603-012-0085-1.

PMID:
23208027
22.

Expression of inhibin/activin proteins and receptors in the human hypothalamus and basal forebrain.

Miller MC, Lambert-Messerlian GM, Eklund EE, Heath NL, Donahue JE, Stopa EG.

J Neuroendocrinol. 2012 Jun;24(6):962-72. doi: 10.1111/j.1365-2826.2012.02289.x.

PMID:
22296042
23.

Changes in brain β-amyloid deposition and aquaporin 4 levels in response to altered agrin expression in mice.

Rauch SM, Huen K, Miller MC, Chaudry H, Lau M, Sanes JR, Johanson CE, Stopa EG, Burgess RW.

J Neuropathol Exp Neurol. 2011 Dec;70(12):1124-37. doi: 10.1097/NEN.0b013e31823b0b12.

24.

Esophageal cancer related gene-4 is a choroid plexus-derived injury response gene: evidence for a biphasic response in early and late brain injury.

Podvin S, Gonzalez AM, Miller MC, Dang X, Botfield H, Donahue JE, Kurabi A, Boissaud-Cooke M, Rossi R, Leadbeater WE, Johanson CE, Coimbra R, Stopa EG, Eliceiri BP, Baird A.

PLoS One. 2011;6(9):e24609. doi: 10.1371/journal.pone.0024609. Epub 2011 Sep 14.

25.

Ecrg4 expression and its product augurin in the choroid plexus: impact on fetal brain development, cerebrospinal fluid homeostasis and neuroprogenitor cell response to CNS injury.

Gonzalez AM, Podvin S, Lin SY, Miller MC, Botfield H, Leadbeater WE, Roberton A, Dang X, Knowling SE, Cardenas-Galindo E, Donahue JE, Stopa EG, Johanson CE, Coimbra R, Eliceiri BP, Baird A.

Fluids Barriers CNS. 2011 Jan 18;8(1):6. doi: 10.1186/2045-8118-8-6.

26.

Targeting choroid plexus epithelia and ventricular ependyma for drug delivery to the central nervous system.

Gonzalez AM, Leadbeater WE, Burg M, Sims K, Terasaki T, Johanson CE, Stopa EG, Eliceiri BP, Baird A.

BMC Neurosci. 2011 Jan 7;12:4. doi: 10.1186/1471-2202-12-4.

27.

Targeting the choroid plexus-CSF-brain nexus using peptides identified by phage display.

Baird A, Eliceiri BP, Gonzalez AM, Johanson CE, Leadbeater W, Stopa EG.

Methods Mol Biol. 2011;686:483-98. doi: 10.1007/978-1-60761-938-3_25.

28.

The blood-cerebrospinal fluid barrier: structure and functional significance.

Johanson CE, Stopa EG, McMillan PN.

Methods Mol Biol. 2011;686:101-31. doi: 10.1007/978-1-60761-938-3_4. Review.

PMID:
21082368
29.

Decreased serum BDNF levels in patients with epileptic and psychogenic nonepileptic seizures.

LaFrance WC Jr, Leaver K, Stopa EG, Papandonatos GD, Blum AS.

Neurology. 2010 Oct 5;75(14):1285-91. doi: 10.1212/WNL.0b013e3181f612bb. Erratum in: Neurology. 2011 Mar 8;76(10):935.

30.

Amyloid efflux transporter expression at the blood-brain barrier declines in normal aging.

Silverberg GD, Messier AA, Miller MC, Machan JT, Majmudar SS, Stopa EG, Donahue JE, Johanson CE.

J Neuropathol Exp Neurol. 2010 Oct;69(10):1034-43. doi: 10.1097/NEN.0b013e3181f46e25.

PMID:
20838242
31.

Co-localization and regulation of basic fibroblast growth factor and arginine vasopressin in neuroendocrine cells of the rat and human brain.

Gonzalez AM, Taylor WM, Johanson CE, King JC, Leadbeater WE, Stopa EG, Baird A.

Cerebrospinal Fluid Res. 2010 Aug 13;7:13. doi: 10.1186/1743-8454-7-13.

32.

Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease.

Ott BR, Cohen RA, Gongvatana A, Okonkwo OC, Johanson CE, Stopa EG, Donahue JE, Silverberg GD; Alzheimer's Disease Neuroimaging Initiative.

J Alzheimers Dis. 2010;20(2):647-57. doi: 10.3233/JAD-2010-1406.

33.

Amyloid deposition and influx transporter expression at the blood-brain barrier increase in normal aging.

Silverberg GD, Miller MC, Messier AA, Majmudar S, Machan JT, Donahue JE, Stopa EG, Johanson CE.

J Neuropathol Exp Neurol. 2010 Jan;69(1):98-108. doi: 10.1097/NEN.0b013e3181c8ad2f.

PMID:
20010299
34.

Activation of suprachiasmatic nuclei and primary visual cortex depends upon time of day.

Vimal RL, Pandey-Vimal MU, Vimal LS, Frederick BB, Stopa EG, Renshaw PF, Vimal SP, Harper DG.

Eur J Neurosci. 2009 Jan;29(2):399-410. doi: 10.1111/j.1460-9568.2008.06582.x.

PMID:
19200242
35.

Ontogeny of connexin 32 and 43 expression in the cerebral cortices of ovine fetuses, newborns, and adults.

Sadowska GB, Stopa EG, Stonestreet BS.

Brain Res. 2009 Feb 19;1255:51-6. doi: 10.1016/j.brainres.2008.12.004. Epub 2008 Dec 11.

36.

Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease.

Miller MC, Tavares R, Johanson CE, Hovanesian V, Donahue JE, Gonzalez L, Silverberg GD, Stopa EG.

Brain Res. 2008 Sep 16;1230:273-80. doi: 10.1016/j.brainres.2008.06.124. Epub 2008 Jul 14.

37.

Multiplicity of cerebrospinal fluid functions: New challenges in health and disease.

Johanson CE, Duncan JA 3rd, Klinge PM, Brinker T, Stopa EG, Silverberg GD.

Cerebrospinal Fluid Res. 2008 May 14;5:10. doi: 10.1186/1743-8454-5-10.

38.

Dorsomedial SCN neuronal subpopulations subserve different functions in human dementia.

Harper DG, Stopa EG, Kuo-Leblanc V, McKee AC, Asayama K, Volicer L, Kowall N, Satlin A.

Brain. 2008 Jun;131(Pt 6):1609-17. doi: 10.1093/brain/awn049. Epub 2008 Mar 27.

39.

Cerebral cortical arteriolar angiopathy, vascular beta-amyloid, smooth muscle actin, Braak stage, and APOE genotype.

Stopa EG, Butala P, Salloway S, Johanson CE, Gonzalez L, Tavares R, Hovanesian V, Hulette CM, Vitek MP, Cohen RA.

Stroke. 2008 Mar;39(3):814-21. doi: 10.1161/STROKEAHA.107.493429. Epub 2008 Feb 7. Erratum in: Stroke. 2010 Aug;41(8):e551.

PMID:
18258839
40.

Microinfusion into the rat brain of antibodies against Semliki Forest Virus produces changes in behavioral response to apomorphine.

Knopf PM, Harling-Berg CJ, Lee DJ, Hallett JJ, Stopa EG, Mokhtarian F.

J Neuroimmunol. 2007 Mar;184(1-2):149-55. Epub 2007 Jan 25.

PMID:
17257687
41.

RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease.

Donahue JE, Flaherty SL, Johanson CE, Duncan JA 3rd, Silverberg GD, Miller MC, Tavares R, Yang W, Wu Q, Sabo E, Hovanesian V, Stopa EG.

Acta Neuropathol. 2006 Oct;112(4):405-15. Epub 2006 Jul 25.

PMID:
16865397
42.

Microvascular injury and blood-brain barrier leakage in Alzheimer's disease.

Zipser BD, Johanson CE, Gonzalez L, Berzin TM, Tavares R, Hulette CM, Vitek MP, Hovanesian V, Stopa EG.

Neurobiol Aging. 2007 Jul;28(7):977-86. Epub 2006 Jun 16.

PMID:
16782234
43.

Musashi1 antigen expression in human fetal germinal matrix development.

Chan C, Moore BE, Cotman CW, Okano H, Tavares R, Hovanesian V, Pinar H, Johanson CE, Svendsen CN, Stopa EG.

Exp Neurol. 2006 Oct;201(2):515-8. Epub 2006 Jun 14.

PMID:
16777095
44.

Atrial natriuretic peptide: its putative role in modulating the choroid plexus-CSF system for intracranial pressure regulation.

Johanson CE, Donahue JE, Spangenberger A, Stopa EG, Duncan JA, Sharma HS.

Acta Neurochir Suppl. 2006;96:451-6.

PMID:
16671503
45.

Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route.

Johanson CE, Duncan JA, Stopa EG, Baird A.

Pharm Res. 2005 Jul;22(7):1011-37. Epub 2005 Jul 22. Review.

PMID:
16028003
46.

Disturbance of endogenous circadian rhythm in aging and Alzheimer disease.

Harper DG, Volicer L, Stopa EG, McKee AC, Nitta M, Satlin A.

Am J Geriatr Psychiatry. 2005 May;13(5):359-68.

PMID:
15879584
47.

Spontaneous lobar haemorrhage in CADASIL.

Maclean AV, Woods R, Alderson LM, Salloway SP, Correia S, Cortez S, Stopa EG.

J Neurol Neurosurg Psychiatry. 2005 Mar;76(3):456-7. No abstract available.

48.
49.

Effects of exogenous glucose on brain ischemia in ovine fetuses.

Petersson KH, Pinar H, Stopa EG, Sadowska GB, Hanumara RC, Stonestreet BS.

Pediatr Res. 2004 Oct;56(4):621-9. Epub 2004 Aug 19.

PMID:
15319457
50.

Dementia severity and Lewy bodies affect circadian rhythms in Alzheimer disease.

Harper DG, Stopa EG, McKee AC, Satlin A, Fish D, Volicer L.

Neurobiol Aging. 2004 Jul;25(6):771-81.

PMID:
15165702

Supplemental Content

Loading ...
Support Center